8. Potential risks of nanoparticles
The use of nanomaterials is becoming very commonplace. According to the European Commission, the global nanotechnology market is expected to reach €1,000 billion a year between 2010 and 2015. Investment in research and development is very high, particularly in the medical field. Beyond the examples of nanoparticle use as antimicrobial reagents mentioned in this article, many other studies are underway. These studies are reinforced by the fact that the majority of known antibiotics only partially kill the pathogens that cause disease. The rapid development of new technologies makes it possible to produce particles of the desired size and shape, and to optimize their antimicrobial activity. Decreasing particle size increases the surface area of contact with microbes, thus significantly boosting efficacy. On the other hand, the nanometric scale of measurement changes the properties and/or...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Nanosciences and nanotechnologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Potential risks of nanoparticles
Bibliography
Websites
In 2002, the European Union set up the 6th Framework Program called Nano2Life. http://www.nano2life.org
Among the national networks, we should mention "C'NANO Île-de-France". http://www.cnanoidf.org/
Other advisor leads.
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference